重视对视网膜母细胞瘤患儿的个体化综合治疗

视网膜母细胞瘤（RB）是发生于婴幼儿时期最为常见的眼内恶性肿瘤。随着新治疗方法的不断出现,传统的RB治疗目标和治疗模式已逐步转变为以保留眼球和视功能作为前提的个体化综合治疗新模式。与国外发达国家相比,我国在RB的临床治疗新思路和个体化综合治疗新手段等方面尚有较大差距。目前,多数医院仍首选眼球摘除术,同时以外部放射治疗作为补充,其治疗模式相对滞后、局限和单一。因此,国内临床眼科医师应重视结合我国RB的实际发病情况,改变以往的传统治疗理念,合理借鉴国外的先进治疗经验,积极探索并逐步建立起切实可行的RB个体化综合治疗新模式。（中华职科杂志,2007,43：481-483）

Recognize the value of the individually combined therapy for children with retinoblastoma

Retinoblastoma is the most common intraocular malignant tumor in children. With the introduction of the new therapeutic methods, the aim and the procedures of traditional therapy on retinoblastoma have been changed to the new combined therapeutic procedures, which are based on the preservation of the eyeball and visual function. Compared with the developed countries, there still exist some gaps in the acceptance of new therapeutic conceptions in China. At present, enucleation is still used commonly in China, whereas external beam radiation therapy is a main supplementary treatment. The therapeutic procedures of RB in China are relatively limited and simplistic. Therefore, the authors suggest that we should learn the experience from the developed countries, considering the status in our country, to change the traditional therapeutic idea and to establish a suitable system of individually combined therapy for patients with retinoblastoma in China.